Drug Shortage Report for TEVA-CLONIDINE

Last updated on 2025-05-08 History

Report ID	242344
Drug Identification Number	02046121
Brand name	TEVA-CLONIDINE
Common or Proper name	TEVA-CLONIDINE 0.1MG TAB
Company Name	TEVA CANADA LIMITED
Market Status	MARKETED
Active Ingredient(s)	CLONIDINE HYDROCHLORIDE
Strength(s)	0.1MG
Dosage form(s)	TABLET
Route of administration	ORAL ORAL
Packaging sizes (GTIN) Click here to see a list of all reports for this drug.	(See additional packaging sizes)
Additional packaging sizes	100
ATC code	C02AC
ATC description	ANTIADRENERGIC AGENTS, CENTRALLY ACTING
Reason for shortage	Disruption of the manufacture of the drug.
Anticipated start date
Actual start date	2024-11-07
Estimated end date	2025-05-10
Actual end date	2025-05-07
Shortage status	Resolved
Updated date	2025-05-08
Company comments
Health Canada comments
Tier 3 Status	No
Contact Address	30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Showing 1 to 20 of 30